IDO expression by ovarian tumor cells or infiltrating myeloid cells arguably forms one of the cornerstones of immune regulation in ovarian cancer, and it is no surprise that high IDO expression is associated with diminished overall survival. This evidence concerns the gene IDO1 and ovarian carcinoma.